About Scott Chaverri

Scott Chaverri is the founder and CEO of Mito Red Light, one of the leading manufacturers of clinical-grade red and near-infrared light therapy devices in the United States. He holds a BA in Psychology from Cornell University and an MBA in Finance from the Simon School of Business at the University of Rochester, and spent over a decade working across Fortune 500 companies in medical devices, financial services, and e-commerce before founding Mito Red Light.

Scott's path to photobiomodulation was driven by personal health challenges in childhood and early adulthood that led him to deeply research the evidence base for non-invasive, light-based therapies. He founded Mito Red Light with the mission of bringing clinical-grade photobiomodulation devices to home users and businesses at accessible price points, supported by rigorous scientific transparency.

Under Scott's leadership, Mito Red Light has grown to serve over 100,000 customers, earned multiple ETL certifications, received FDA registration, holds multiple patents on its multi-wavelength device technology, and has been featured in press including CBS Los Angeles. Scott is an active science communicator and has discussed the evidence base for red light therapy on more than a dozen podcasts, including appearances with Princeton researcher Dr. Alexis Cowan, Dr. Gabrielle Lyon, and others in the health optimization and longevity space.